Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
SUPN
#1407
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.48%
Monthly Change
+10.77%
6 month change
+1.35%
Cambio anual
+1.35%
Cierres anteriores
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
Volumen
97
Markets
Acciones
Atención Sanitaria
SUPN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
TD Cowen relève l’objectif de cours de Supernus Pharmaceuticals suite au relancement d’Onapgo
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
L’action Supernus Pharmaceuticals atteint un sommet de 52 semaines à 57,76$
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald réitère sa note de surpondération sur Supernus grâce aux gains d’approvisionnement
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Le BPA de Supernus a manqué les attentes de 0,48$, le CA a surpassé les prévisions
Supernus earnings missed by $0.48, revenue topped estimates
Supernus face au test des résultats après le choc de rentabilité du T3
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline